Summary

Foot and Ankle Device Market Research Report by Device Type [Orthopedic Implants and Devices (Fixation Devices, Joint Implants), Soft-Tissue Management Devices (Artificial Tendons & Ligaments, Musculoskeletal Reinforcement Devices), Prostheses (Solid Ankle Cushion Heel (SACH) Foot, Single-Axial Prostheses, Multiaxial Prostheses, Dynamic Response/Energy Storing Prostheses, Microprocessor Controlled (Mpc) Prostheses), Bracing and Support Devices], by Application (Trauma, Diabetes, Neurological Disorders, Midfoot Arthrodesis, Deformity Correction, Others), by End User (Hospitals & Clinics, Physiotherapy Centers, Academic & Research Organizations), and by Region (North America, Europe, Asia-Pacific, South America, MEA) Forecast till 2035

Market Overview
The global Foot and Ankle Device Market is projected to reach USD 12,680.65 million by 2035, growing at a CAGR of 7.32% from 2025 to 2035. A foot and ankle device refers to medical equipment or implants designed to support, correct, or replace damaged bones, joints, and tissues in the lower extremities. These devices are commonly used in treating fractures, arthritis, and deformities to restore mobility and stability.
A primary factor contributing to the growth of the global Foot and Ankle Device Market is the growing awareness and education of patients on early diagnosis and preventive care. Access to a wealth of medical information on the internet and through advocacy groups has led patients to seek timely treatment and rehabilitation devices. This awareness is boosting the demand for non-invasive orthopedic solutions such as braces, insoles, and orthotics, thereby propelling innovation and overall market growth worldwide.

Key Company Development
The awareness contributes to the increase in demand for non-invasive orthopedic devices such as braces, insoles, and orthoses. Thus, it serves as a high-growth area for innovation and overall growth of the global market. Key Company Developments Orthofix Medical Inc. has recorded considerable growth with key developments over the past few years. In September 2023, the company successfully launched its Galaxy Fixation Gemini system in the United States of America. In March 2020, Orthofix strengthened its portfolio by acquiring FITBONE assets, designed for limb lengthening of the femur and tibia bones.

Major Players
Major competitors in the global foot and ankle device market are Stryker, Smith+Nephew, Globus Medical, Inc., CONMED Corporation, Johnson & Johnson Inc., Zimmer Biomet, Acumed LLC, Orthox Medical Inc., Arthrex, Inc., and Invibio Ltd.

Report Attribute Details
- Market Size 2024: USD 5,885.75 Million
- Market Size 2035: USD 12,680.65 Million
- CAGR (2025-2035): 7.32%
- Base Year: 2024
- Market Forecast Period: 2025-2035

Market Segmentations
- By Device Type: Orthopedic Implants and Devices - 7.54%, Soft-Tissue Management Devices - 11.61%.
- By Application: Trauma - 7.65%, Diabetes - 9.85%.
- By End User: Hospitals & Clinics - 7.31%, Physiotherapy Centers - 8.81%.

Regional Insights
The growth of the North America region is promoted by the presence of an advanced healthcare infrastructure, high patient awareness, and the availability of new orthopedic products. The participation of the USA is significant due to its quick acceptance of modern medical technologies and excellent insurance coverage. The country of Canada also shows steady growth due to various government schemes assisting accessibility to orthopedic care.
The growth in Europe is mainly due to the growth in the incidence of sports injuries, arthritis, and foot complications arising as a result of diabetes. Countries such as Germany, France, and the UK are at the forefront of medical device innovations, supported by well-structured healthcare systems.
Asia-Pacific's Foot and Ankle Device Market reached USD 1,111.63 million in 2024 and is estimated to expand at a notable CAGR of 9.37% during the forecast period. The rapid increase in healthcare expenditure, coupled with improving hospital infrastructure, is fueling market demand in countries like China, India, and Japan.
In Latin America, the Foot and Ankle Device Market accounted for USD 211.31 million in 2024 and is projected to grow at a CAGR of 5.54%. The market expansion is supported by growing healthcare investments and an increasing focus on orthopedic rehabilitation. Brazil and Mexico lead the regional market with rising demand for minimally invasive surgical devices.
The Middle East and Africa Foot and Ankle Device Market was valued at USD 178.44 million in 2024, expected to rise at a CAGR of 6.07%. Growth is supported by expanding hospital infrastructure and a rising burden of lifestyle-related foot disorders. GCC countries are at the forefront, investing heavily in modern medical technologies.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ....... 25
2 MARKET INTRODUCTION .... 27
2.1 DEFINITION ....... 27
2.2 SCOPE OF THE STUDY ..... 27
2.3 RESEARCH OBJECTIVE .... 27
2.4 MARKET STRUCTURE ..... 28
3 RESEARCH METHODOLOGY ...... 29
3.1 OVERVIEW .... 29
3.2 DATA FLOW ...... 31
3.2.1 DATA MINING PROCESS ..... 31
3.3 PURCHASED DATABASE: .... 32
3.4 SECONDARY SOURCES: ...... 33
3.4.1 SECONDARY RESEARCH DATA FLOW: ..... 34
3.5 PRIMARY RESEARCH: ..... 35
3.5.1 PRIMARY RESEARCH DATA FLOW: ..... 36
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ..... 37
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ...... 37
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ...... 38
3.6.1 REVENUE ANALYSIS APPROACH ..... 38
3.7 DATA FORECASTING....... 39
3.7.1 DATA FORECASTING TYPE ...... 39
3.8 DATA MODELING .... 40
3.8.1 MICROECONOMIC FACTOR ANALYSIS: .... 40
3.8.2 DATA MODELING: ....... 41
3.9 TEAMS AND ANALYST CONTRIBUTION ..... 43
4 MARKET DYNAMICS .... 45
4.1 INTRODUCTION ....... 45
4.2 DRIVERS ..... 45
4.2.1 INCREASING INCIDENCE OF SPORTS-RELATED INJURIES ..... 45
4.2.2 RISING AWARENESS AND PATIENT EDUCATION ...... 46
4.2.3 RESEARCH AND INNOVATION ..... 46
4.3 RESTRAINTS ...... 47
4.3.1 STRINGENT REGULATORY REQUIREMENTS...... 47
4.3.2 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS ..... 47
4.4 OPPORTUNITY ..... 49
4.4.1 GROWING GERIATRIC POPULATION .... 49
4.4.2 TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN .... 49
5 MARKET FACTOR ANALYSIS ...... 50
5.1 PORTER'S FIVE FORCES MODEL ....... 50
5.1.1 THREAT OF NEW ENTRANTS ....... 50
5.1.2 BARGAINING POWER OF SUPPLIERS ....... 51
5.1.3 THREAT OF SUBSTITUTES ...... 51
5.1.4 BARGAINING POWER OF BUYERS .... 51
5.1.5 INTENSITY OF RIVALRY ...... 51
5.2 IMPACT OF COVID-19 ON THE GLOBAL FOOT AND ANKLE DEVICE MARKET ..... 52
6 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY DEVICE TYPE .... 55
6.1 OVERVIEW .... 55
6.2 ORTHOPEDIC IMPLANTS AND DEVICES .... 58
6.2.1 FIXATION DEVICES ..... 59
6.2.1.1 INTERNAL FIXATION DEVICES..... 60
6.2.1.1.1 SCREWS ....... 61
6.2.1.1.2 PLATES .... 62
6.2.1.1.3 WIRES & PINS ....... 62
6.2.1.1.4 FUSION NAILS ...... 63
6.2.1.1.5 STAPLE .... 63
6.2.1.2 EXTERNAL FIXATION DEVICES .... 64
6.2.1.2.1 UNILATERAL FIXATORS ..... 65
6.2.1.2.2 RING ANKLE FIXATORS ..... 65
6.2.1.2.3 HYBRID FIXATORS .... 66
6.2.2 JOINT IMPLANTS ....... 66
6.2.2.1 ANKLE IMPLANTS (ANKLE REPLACEMENT DEVICES) ....... 67
6.2.2.2 SUBTALAR JOINT IMPLANTS/SUBTALAR JOINT RECONSTRUCTION DEVICES ....... 68
6.2.2.3 PHALANGEAL IMPLANTS ....... 68
6.3 SOFT-TISSUE MANAGEMENT DEVICES ....... 69
6.3.1 ARTIFICIAL TENDONS & LIGAMENTS ....... 70
6.3.2 MUSCULOSKELETAL REINFORCEMENT DEVICES ..... 70
6.4 PROSTHESES...... 71
6.4.1 SOLID ANKLE CUSHION HEEL (SACH) FOOT .... 73
6.4.2 SINGLE-AXIAL PROSTHESES ....... 73
6.4.3 MULTIAXIAL PROSTHESES ..... 74
6.4.4 DYNAMIC RESPONSE/ENERGY-STORING PROSTHESES .... 74
6.4.5 MICROPROCESSOR-CONTROLLED (MPC) PROSTHESES.... 75
6.5 BRACING AND SUPPORT DEVICES ....... 75
7 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY APPLICATION .... 76
7.1 OVERVIEW .... 76
7.2 TRAUMA .... 78
7.3 DIABETES ....... 79
7.4 NEUROLOGICAL DISORDERS .... 79
7.5 MIDFOOT ARTHRODESIS ....... 80
7.6 DEFORMITY CORRECTION .... 80
7.7 OTHERS ...... 81
8 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY END USER ..... 82
8.1 OVERVIEW .... 82
8.2 HOSPITALS & CLINICS .... 84
8.3 PHYSIOTHERAPY CENTERS ....... 85
8.4 ACADEMIC & RESEARCH ORGANIZATIONS ...... 85
9 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY REGION ..... 86
9.1 OVERVIEW .... 86
9.2 NORTH AMERICA .... 87
9.2.1 US...... 93
9.2.2 CANADA .... 97
9.3 EUROPE ...... 101
9.3.1 GERMANY ...... 107
9.3.2 FRANCE ..... 111
9.3.3 UK ..... 115
9.3.4 ITALY ..... 119
9.3.5 SPAIN .... 123
9.3.6 RUSSIA ...... 127
9.3.7 REST OF EUROPE .... 131
9.4 ASIA PACIFIC .... 136
9.4.1 CHINA .... 142
9.4.2 INDIA ..... 146
9.4.3 JAPAN ....... 150
9.4.4 SOUTH KOREA .... 154
9.4.5 MALAYSIA ..... 158
9.4.6 THAILAND ...... 162
9.4.7 INDONESIA ..... 166
9.4.8 REST OF ASIA PACIFIC.... 170
9.5 SOUTH AMERICA ..... 175
9.5.1 BRAZIL ....... 181
9.5.2 MEXICO ..... 185
9.5.3 ARGENTINA ....... 189
9.5.4 REST OF SOUTH AMERICA ...... 193
9.6 MIDDLE EAST AND AFRICA ....... 198
9.6.1 GCC COUNTRIES..... 204
9.6.2 SOUTH AFRICA ....... 209
9.6.3 REST OF MEA ..... 213
10 COMPETITIVE LANDSCAPE .... 219
10.1 INTRODUCTION ....... 219
10.2 MARKET SHARE ANALYSIS, 2024 ...... 219
10.3 COMPETITOR DASHBOARD ...... 220
10.4 PUBLIC PLAYERS STOCK SUMMARY ....... 221
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ....... 221
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 222
10.6.1 PRODUCT LAUNCH ..... 222
10.6.2 PRODUCT APPROVAL ..... 223
10.6.3 PRODUCT EXPANSION .... 223
10.6.4 ACQUISITION ..... 223
10.6.5 PARTNERSHIP .... 224
11 COMPANY PROFILES ...... 225
11.1 ORTHOFIX MEDICAL INC....... 225
11.1.1 COMPANY OVERVIEW ..... 225
11.1.2 FINANCIAL OVERVIEW .... 226
11.1.3 PRODUCTS OFFERED ...... 227
11.1.4 KEY DEVELOPMENTS ...... 227
11.1.5 SWOT ANALYSIS .... 228
11.1.6 KEY STRATEGIES .... 228
11.2 ARTHREX, INC. ..... 229
11.2.1 COMPANY OVERVIEW ..... 229
11.2.2 FINANCIAL OVERVIEW .... 229
11.2.3 PRODUCTS OFFERED ...... 229
11.2.4 KEY DEVELOPMENTS ...... 231
11.2.5 KEY STRATEGIES .... 231
11.3 INVIBIO LTD. .... 232
11.3.1 COMPANY OVERVIEW ..... 232
11.3.2 FINANCIAL OVERVIEW .... 232
11.3.3 PRODUCT OFFERED .... 232
11.3.4 KEY DEVELOPMENTS ...... 232
11.3.5 SWOT ANALYSIS .... 233
11.3.6 KEY STRATEGIES .... 233
11.4 STRYKER .... 234
11.4.1 COMPANY OVERVIEW .... 234
11.4.2 FINANCIAL OVERVIEW .... 235
11.4.3 PRODUCTS OFFERED ...... 236
11.4.4 KEY DEVELOPMENTS ...... 237
11.4.5 SWOT ANALYSIS .... 238
11.4.6 KEY STRATEGIES .... 238
11.5 SMITH+NEPHEW ...... 239
11.5.1 COMPANY OVERVIEW ..... 239
11.5.2 FINANCIAL OVERVIEW .... 240
11.5.3 PRODUCTS OFFERED ...... 240
11.5.4 KEY DEVELOPMENTS ...... 241
11.5.5 SWOT ANALYSIS .... 242
11.5.6 KEY STRATEGIES .... 242
11.6 GLOBUS MEDICAL, INC....... 243
11.6.1 COMPANY OVERVIEW ..... 243
11.6.2 FINANCIAL OVERVIEW .... 244
11.6.3 PRODUCTS OFFERED ...... 244
11.6.4 KEY DEVELOPMENTS ...... 245
11.6.5 KEY STRATEGIES .... 245
11.7 CONMED CORPORATION ...... 246
11.7.1 COMPANY OVERVIEW ..... 246
11.7.2 FINANCIAL OVERVIEW .... 247
11.7.3 PRODUCTS OFFERED ...... 247
11.7.4 KEY DEVELOPMENTS ...... 248
11.7.5 KEY STRATEGIES .... 248
11.8 JOHNSON & JOHNSON SERVICES, INC ..... 249
11.8.1 COMPANY OVERVIEW ..... 249
11.8.2 FINANCIAL OVERVIEW .... 250
11.8.3 PRODUCTS OFFERED ...... 251
11.8.4 KEY DEVELOPMENTS ...... 252
11.8.5 SWOT ANALYSIS .... 253
11.8.6 KEY STRATEGIES .... 253
11.9 ZIMMER BIOMET HOLDINGS, INC. ...... 254
11.9.1 COMPANY OVERVIEW ..... 254
11.9.2 FINANCIAL OVERVIEW .... 255
11.9.3 PRODUCTS OFFERED ...... 256
11.9.4 KEY DEVELOPMENTS ...... 256
11.9.5 KEY STRATEGIES .... 257
11.10 ACUMED LLC .... 258
11.10.1 COMPANY OVERVIEW ..... 258
11.10.2 FINANCIAL OVERVIEW .... 259
11.10.3 PRODUCT OFFERED .... 259
11.10.4 KEY DEVELOPMENTS ...... 259
11.10.5 KEY STRATEGIES .... 260
12 DATA CITATIONS ..... 261